Orbital plasmablastic lymphomacomparison of a newly reported entity with diffuse large b-cell lymphoma of the orbit

Orbit

Volumn 28, Issue 6, 2009, Pages 425-429

  Morley, Ana M S ^a   Verity, David H ^a   Meligonis, George ^a   Rose, Geoffrey E ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

HIV; Lymphoma; Orbit; Plasmablastic; Sinonasal

Indexed keywords

BLEOMYCIN; CD20 ANTIGEN; CD79A ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; KI 67 ANTIGEN; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; SYNDECAN 1; VINCRISTINE; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL; DOXORUBICIN; LEUKOCYTE ANTIGEN; PREDNISONE; TUMOR MARKER;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC SURGERY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; ORBIT TUMOR; ORBITAL PLASMABLASTIC LYMPHOMA; PROGNOSIS; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FATALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PATHOLOGY; PLASMA CELL;

ADULT; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FATAL OUTCOME; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; ORBITAL NEOPLASMS; PLASMA CELLS; PREDNISONE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 71149121469     PISSN: 01676830     EISSN: 17445108     Source Type: Journal    
DOI: 10.3109/01676830903177427     Document Type: Article

References (24)

1. Barkhuysen R, Merkx MA, Weijs WL, et al. Plasmablastic lymphoma mimicking orbital cellulitis. Oral Maxillofac Surg. 2008;12(3):125-128
2. Carbone A, Gloghini A. Plasmablastic lymphoma: one or more entities? Am J Hematol. 2008;83(10):763-764
3. Chetty R, Hlatswayo N, Muc R, et al. Plasmablastic lymphoma in HIV+ patients: And expanding spectrum. Histopathology. 2003:42(6):605-609
4. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28(6):736--747.
5. Dales JP, Harket A, Bagneres D, et al. Plasmablastic lymphoma in a patient with HIV infection: And unusual case located in the skin. Ann Pathol. 2005;25(1):45-49
6. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic Lymphomas of the oral cavity: A new entity associated with the Human Immunodeficiency Virus infection. Blood. 1997;89(4):1413-1420
7. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: And aggressive Epstein-Barr virus-associated extranedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29(12):1633-1641
8. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95(4):1406-1412
9. Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: An unrecognized cutaneous manifestation. Dermatology. 2004;208(3):287-290
10. Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000,84(8):907-913
11. Jordan LB, Lessells AM, Goodlad JR. Plasmablastic lymphoma arising at a cutaneous site. Histopathology. 2005;46(1):113-115
12. Lin Y, Rodrigues GD, Turner JF, Vasef MA. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med. 2001;125(2): 282-285 (Pubitemid 32167487)
13. Little RF, Pittaluga S, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndromerelated lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumour biology. Blood. 2003;101:4653-4659
14. Nguyen DD, Loo BW, Tillman G, et al. plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: A case report. Ann Haematol. 2003;82(8):521-525
15. Nicol I, Boye T, Carsuzaa F, et al. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol. 2003;149(4):889-891
16. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirusrelated non-Hodgkin lymphoma in patients with HIV infection and munticentric Castleman disease. Blood. 2002;99(7):2331-2336
17. Pruneri G, Graziadei G, Ermellino L, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica. 1998;83(1):87-89
18. Robak T, Urbanska-Rys H, Strzelecka B, et al. Plasmablastic lymphoma in a patient with chronic lymphocytic leukaemia heavily pretreated with cladribine (2-CdA): An unusual variant of Richter's syndrome. Eur J Haematol. 2001;67 (5-6):322-327
19. Scheper MA, Nikitakis NG, Fernandes R, et al. Oral plasmablastic lymphoma in an HIV-negative patient: A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(2):198-206
20. Schichman SA, McLure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in sinus, testicles and bones: A further expansion of the disease spectrum. Am J Haematol. 2004;77(3):291-295
21. Swerdlow SH, Campo E, Harris NL, Jaffe ES, et al. Editors: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon. 2008. P256-257
22. Tavora F, Gonzalez-Cuyar LF, Sun CCJ, et al. Extra-oral plasmablastic lymphoma: report of a case and review of the literature. Human Pathology. 2006;37(9):1233-1236
23. Valenzuela AA, Walker NJ, Sullivan TJ. Plasmablastic lymphoma in the orbit: case report. Orbit. 2008;27(3): 227-229
24. Verma S, Nuovo GJ, Porcu P, et al. Epstein-Barr virusand human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol. 2005;32(1):35-39